Clinical profile and incidence of ventricular arrhythmia in patients undergoing defibrillator generator replacement in Spain;Perfil clínico e incidencia de arritmias ventriculares de los pacientes sometidos a recambio de generador de desfibrilador en España

Revista Espanola de Cardiologia

Volumn 67, Issue 12, 2014, Pages 986-992

  Fontenla, Adolfo ^a   López Gil, María ^a   Martínez Ferrer, José ^b   Alzueta, Javier ^c   Fernández Lozano, Ignacio ^d   Viñolas, Xavier ^e   Rodríguez, Aníbal ^f   Fernández De La Concha, Joaquín ^g   Anguera, Ignasi ^h   Arribas, Fernando ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^g HOSPITAL INFANTA CRISTINA   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Appropriate therapies; Generator replacement; Implantable cardioverter defibrillator; Ventricular arrhythmias

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; FOLLOW UP; GENERATOR; GENERATOR REPLACEMENT; HEART DISEASE; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; REMOTE SENSING; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPAIN; TREATMENT OUTCOME; ADVERSE EFFECTS; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL; DEVICE FAILURE; MIDDLE AGED; RISK ASSESSMENT;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SPAIN;

EID: 84922534212     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.01.019     Document Type: Article

References (38)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias The antiarrhythmics versus implantable defibrillators (AVID) investigators N Engl J Med 337 1997 1576 1583
2. S.J. Connolly, M. Gent, R.S. Roberts, P. Dorian, D. Roy, and R.S. Sheldon Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
3. K.H. Kuck, R. Cappato, J. Siebels, and R. Rüppel Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748 754
4. A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, and H. Klein Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia Multicenter automatic defibrillator implantation trial investigators N Engl J Med 335 1996 1933 1940
5. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
6. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, and D.S. Cannom Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
7. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and T. De Marco Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
8. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, and R. Boineau Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
9. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes 3rd, R.A. Freedman, and L.S. Gettes ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
10. J.A. Camm, and S. Nisam European utilization of the implantable defibrillator: Has 10 years changed the 'enigma'? Europace 12 2010 1063 1069
11. M.O. Sweeney, M.S. Wathen, K. Volosin, I. Abdalla, P.J. DeGroot, and M.F. Otterness Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial Circulation 111 2005 2898 2905
12. J.B. Van Rees, C.J. Borleffs, M.K. De Bie, T. Stijnen, L. Van Erven, and J.J. Bax Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
13. S.S. Heller, M.A. Ormont, L. Lidagoster, R.R. Sciacca, and S. Steinberg Psychosocial outcome after ICD implantation: a current perspective Pacing Clin Electrophysiol 21 1998 1207 1215
14. G.D. Sanders, M.A. Hlatky, and D.K. Owens Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 2005 1471 1480
15. D.B. Kramer, A.E. Buxton, and P.J. Zimetbaum Time for a change - a new approach to ICD replacement N Engl J Med 366 2012 291 293
16. A.D. Krahn, D.S. Lee, D. Birnie, J.S. Healey, E. Crystal, and P. Dorian Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the ontario ICD database Circ Arrhythm Electrophysiol 4 2011 136 142
17. J.E. Poole, M.J. Gleva, T. Mela, M.K. Chung, D.Z. Uslan, and R. Borge Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry Circulation 122 2010 1553 1561
18. C.J. Borleffs, J. Thijssen, M.K. De Bie, J.B. Van Rees, G.H. Van Welsenes, and L. Van Erven Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications Pacing Clin Electrophysiol 33 2010 1013 1019
19. J. Alzueta, A. Linde, A. Barrera, J. Peña, and R. Peinado Registro Español de Desfibrilador Automático Implantable. VI Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2009) Rev Esp Cardiol 63 2010 1468 1481
20. J. Alzueta, and J.M. Fernández Registro Español de Desfibrilador Automático Implantable. VII Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2010) Rev Esp Cardiol 64 2011 1023 1034
21. J. Alzueta, and J.M. Fernández Registro Español de Desfibrilador Automático Implantable. VIII Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2011) Rev Esp Cardiol 65 2012 1019 1029
22. S. Brüllmann, W. Dichtl, U. Paoli, L. Haegeli, C. Schmied, and J. Steffel Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged ≤75 years versus those <75 years Am J Cardiol 109 2012 712 717
23. G.H. Van Welsenes, J.B. Van Rees, C.J.W. Borleffs, S.C. Cannegieter, J.J. Bax, and L. Van Erven Long-term follow up of primary and secondary prevention implantable cardioverter defibrillator patients Europace 13 2011 389 394
24. D. Erkapic, J. Sperzel, S. Stiller, U. Meltendorf, J. Mermi, K. Wegscheider INSURE Investigators Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial - a prospective multicentre study Eur Heart J 34 2013 130 137
25. R.T. Borne, P.D. Varosy, and F.A. Masoudi Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches JAMA Intern Med 173 2013 859 865
26. G.H. Van Welsenes, J.B. Van Rees, J. Thijssen, S.A. Trines, L. Van Erven, and M.J. Schalij Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life J Cardiovasc Electrophysiol 22 2011 1346 1350
27. R.L. McSwain, R.A. Schwartz, D.B. DeLurgio, F.V. Mera, J.J. Langberg, and A.R. León The impact of cardiac resynchronization therapy on ventricular tachycardia/fibrillation: an analysis from the combined Contak-CD and InSync-ICD studies J Cardiovasc Electrophysiol 11 2005 1168 1171
28. M. Ikutomi, M. Matsusita, H. Arashi, Y. Watari, G. Endo, and J. Yamaguchi Effects of cardiac resynchronization therapy on the arrhythmic substrate in a patient with long QT and torsades de pointes J Arrhythmia 27 2011 332 337
29. A. Arya, M. Haghjoo, M.R. Dehghani, M. Alasti, H. Alizadeh, and B. Kazemi Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator Heart Rhythm 10 2005 1094 1098
30. S. Shahrzad, N.K. Soleiman, S. Taban, A. Alizadeh, A. Aslani, and A. Tavoosi The effect of left ventricular (LV) remodeling on ventricular arrhythmia in cardiac resynchronization therapy (CRT-D) patients (antiarrhythmic effect of CRT) Pacing Clin Electrophysiol 35 2012 592 597
31. W. Zareba, A.J. Moss, J. Hall, D.J. Wilber, J.N. Ruskin, and S. McNitt Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction J Cardiovasc Electrophysiol 16 2005 1265 1270
32. A.M. Russo, J.D. Day, K. Stolen, C.M. Mullin, V. Doraiswamy, and D.L. Lerew Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial J Cardiovasc Electrophysiol 20 2009 973 978
33. D.R. Davis, A.S. Tang, R. Lemery, M.S. Green, M.H. Gollob, and D.H. Birnie Influence of gender on ICD implantation for primary and secondary prev; ention of sudden cardiac death Europace 8 2006 1054 1056
34. E. OMeara, T. Clayton, M.B. McEntegart, J.J. McMurray, I.L. Piña, C.B. Granger CHARM Investigators Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 115 2007 3111 3120
35. T. Simon, M. Mary-Krause, C. Funck-Brentano, and P. Jaillon Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II) Circulation 103 2001 375 380
36. A. Arshad, A.J. Moss, E. Foster, L. Padeletti, A. Barsheshet, I. Goldenberg MADIT-CRT Executive Committee Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial J Am Coll Cardiol 57 2011 813 820
37. L. Padeletti, D.O. Arnar, L. Boncinelli, J. Brachman, J.A. Camm, J.C. Daubert European Heart Rhythm Association; Heart Rhythm Society EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy Europace 12 2010 1480 1489
38. B.A. Schaer, M.T. Koller, C. Sticherling, D. Altmann, L. Joerg, and S. Osswald Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity Heart Rhythm 6 2009 1737 1743